These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1450796)

  • 1. Upper gastrointestinal complaints and complications in chronic rheumatic patients in comparison with other chronic diseases.
    Janssen M; Dijkmans BA; van der Sluys FA; van der Wielen JG; Havenga K; Vandenbroucke JP; Lamers CB; Zwinderman AH; Cats A
    Br J Rheumatol; 1992 Nov; 31(11):747-52. PubMed ID: 1450796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
    ;
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
    Silverstein FE; Faich G; Goldstein JL; Simon LS; Pincus T; Whelton A; Makuch R; Eisen G; Agrawal NM; Stenson WF; Burr AM; Zhao WW; Kent JD; Lefkowith JB; Verburg KM; Geis GS
    JAMA; 2000 Sep; 284(10):1247-55. PubMed ID: 10979111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
    Wolfe F; Anderson J; Burke TA; Arguelles LM; Pettitt D
    J Rheumatol; 2002 Mar; 29(3):467-73. PubMed ID: 11908558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of clinically manifest ulcers and their complications in patients with rheumatoid arthritis.
    Steen KS; Lems WF; Aertsen J; Bezemer D; Dijkmans BA
    Ann Rheum Dis; 2001 May; 60(5):443-7. PubMed ID: 11302864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasting presentation and findings between patients with rheumatic complaints taking nonsteroidal anti-inflammatory drugs and a general population referred for endoscopy.
    Collins AJ; Davies J; Dixon SA
    Br J Rheumatol; 1986 Feb; 25(1):50-3. PubMed ID: 3484649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
    Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T
    J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron deficiency anaemia in patients with rheumatic disease receiving non-steroidal anti-inflammatory drugs: the role of upper gastrointestinal lesions.
    Upadhyay R; Torley HI; McKinlay AW; Sturrock RD; Russell RI
    Ann Rheum Dis; 1990 Jun; 49(6):359-62. PubMed ID: 2383058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and economic implications of upper gastrointestinal adverse events in Asian rheumatological patients on long-term non-steroidal anti-inflammatory drugs.
    Pok LSL; Shabaruddin FH; Dahlui M; Sockalingam S; Mohamed Said MS; Rosman A; Lau IS; Isa LM; Hussein H; Ng CT; Mahadeva S
    Int J Rheum Dis; 2018 May; 21(5):943-951. PubMed ID: 29314744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and possible risk factors for clinical upper gastrointestinal events in patients taking selective cyclooxygenase-2 inhibitors: A prospective, observational, cohort study in Taiwan.
    Hsiang KW; Chen TS; Lin HY; Luo JC; Lu CL; Lin HC; Lee KC; Chang FY; Lee SD
    Clin Ther; 2010 Jul; 32(7):1294-303. PubMed ID: 20678677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-steroidal anti-inflammatory drug related upper gastrointestinal bleeding: types of drug use and patient profiles in real clinical practice.
    Sostres C; Carrera-Lasfuentes P; Lanas A
    Curr Med Res Opin; 2017 Oct; 33(10):1815-1820. PubMed ID: 28569554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use.
    al-Assi MT; Genta RM; Karttunen TJ; Graham DY
    Endoscopy; 1996 Feb; 28(2):229-33. PubMed ID: 8739738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of peptic ulcer related to rheumatic diseases].
    Imaeda H; Ishii H; Goto M
    Nihon Rinsho; 2002 Aug; 60(8):1585-91. PubMed ID: 12187755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial.
    Chan FKL; Ching JYL; Tse YK; Lam K; Wong GLH; Ng SC; Lee V; Au KWL; Cheong PK; Suen BY; Chan H; Kee KM; Lo A; Wong VWS; Wu JCY; Kyaw MH
    Lancet; 2017 Jun; 389(10087):2375-2382. PubMed ID: 28410791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development and relapse of gastroduodenal ulcer in patients taking nonsteroid anti-inflammatory drugs: effects of standard risk factors].
    Karateev AE; Nasonova VA
    Ter Arkh; 2008; 80(5):62-6. PubMed ID: 18590118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised study of the influence of non-steroidal anti-inflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease.
    Manniche C; Malchow-Møller A; Andersen JR; Pedersen C; Hansen TM; Jess P; Helleberg L; Rasmussen SN; Tage-Jensen U; Nielsen SE
    Gut; 1987 Feb; 28(2):226-9. PubMed ID: 3549473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events.
    Hunt RH; Harper S; Watson DJ; Yu C; Quan H; Lee M; Evans JK; Oxenius B
    Am J Gastroenterol; 2003 Aug; 98(8):1725-33. PubMed ID: 12907325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A NSAID-associated alimentary tract disease in patients with rheumatism in Russia].
    Karataev AE; Konovalova NN; Litovshenko AA; Lomareva NI; Nemtsov BF; Raskina TA; Peshekhonova LK; Nasonov EL
    Klin Med (Mosk); 2005; 83(5):33-8. PubMed ID: 15984580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
    Voutilainen M; Mäntynen T; Färkkilä M; Juhola M; Sipponen P
    Scand J Gastroenterol; 2001 Aug; 36(8):817-21. PubMed ID: 11495076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upper gastrointestinal findings and faecal occult blood in patients with rheumatic diseases taking nonsteroidal anti-inflammatory drugs.
    Collins AJ; Du Toit JA
    Br J Rheumatol; 1987 Aug; 26(4):295-8. PubMed ID: 3496934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.